EUDAMED Is Mandatory: What Medical Buyers Must Check

EUDAMED mandatory use is now a practical procurement issue, not only a regulatory update for manufacturers. Since 28 May 2026, four EUDAMED modules have become mandatory in the EU: Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance (European Commission, June 2026).

For medical buyers, this changes supplier verification. A CE certificate alone is no longer enough. Procurement teams now need to check whether the supplier, device, certificate, and market surveillance information align across EUDAMED and the documentation provided during sourcing.

What EUDAMED mandatory use means for medical buyers

EUDAMED is the European Database on Medical Devices. It was established under the EU Medical Device Regulation and In Vitro Diagnostic Medical Device Regulation to improve transparency, traceability, and coordination across the European medical device system (European Commission, 2026).

The European Commission published Commission Decision (EU) 2025/2371 in the Official Journal on 27 November 2025. That decision confirmed the functionality of the first four modules and triggered a six-month transition period under Regulation (EU) 2024/1860 (European Commission, November 2025).

For buyers, the key point is simple: suppliers placing MDR or IVDR devices on the EU market now operate in a more visible regulatory environment. More data should be available, and inconsistencies should become easier to identify.

Check the supplier’s Actor Registration first

The first buyer check should be the economic operator. Before reviewing price, availability, or product range, confirm who is legally responsible for the device in the EU.

Ask the supplier for its Single Registration Number, where applicable, and confirm whether the company role matches the transaction. The relevant actor may be the manufacturer, authorised representative, importer, or system and procedure pack producer.

This matters because sourcing teams often deal with distributors, local agents, or export departments. EUDAMED helps separate commercial representation from regulatory responsibility.

Verify UDI and device registration data

The UDI/Device module is one of the most important changes for procurement teams. Buyers should request the Basic UDI-DI, UDI-DI, device name, risk class, intended purpose, and manufacturer details, then compare them with the data available in EUDAMED.

The goal is not to turn procurement into regulatory affairs. The goal is to catch mismatches early. A device name that does not match the certificate, a different manufacturer name, or unclear UDI data can indicate outdated documents, private-label confusion, or weak supplier control.

This is especially important when sourcing similar products from different regions. Buyers comparing alternatives should not rely only on product photos, catalogues, or generic CE claims.

Review Notified Body and certificate information

The Notified Bodies & Certificates module became mandatory from 28 May 2026, alongside the Actor and UDI/Device modules (European Commission, June 2026). Buyers should use this as a second-level check after confirming the supplier and device identity.

Ask for the current EU certificate, the notified body number, certificate scope, expiry date, device classification, and any certificate conditions. Then check whether the certificate information matches the device being offered.

Pay attention to scope. A certificate for one product family does not automatically cover every product in a supplier’s catalogue. Buyers should also watch for certificates close to expiry, suspended certificates, or documents that refer to old directives instead of MDR or IVDR where transition rules no longer support the claim.

Check market surveillance signals before shortlisting

The Market Surveillance module is mandatory for competent authorities and the European Commission (European Commission, June 2026). Buyers should understand its purpose even if they do not manage regulatory enforcement directly.

Market surveillance data can affect procurement risk. A supplier may have valid documents but still face concerns related to field safety actions, authority follow-up, or product availability. Procurement teams should therefore ask suppliers whether any market surveillance actions, corrective actions, or safety notices affect the device being sourced.

This check is especially important for high-risk devices, critical hospital supplies, implantable products, and IVDs used in clinical decision-making.

Ask stronger questions before approving new EU suppliers

EUDAMED mandatory use should change buyer questionnaires. Instead of asking only “Do you have CE?” buyers should ask for structured evidence.

Key questions include: What is your actor role in the EU? What is your Single Registration Number? What is the Basic UDI-DI for this device? Which notified body issued the certificate? Does the certificate scope cover the exact product offered? Are there any open regulatory, surveillance, or supply interruption issues affecting this device?

These questions help procurement teams identify suppliers that understand their own regulatory position. Strong manufacturers should be able to answer clearly and consistently.

Do not ignore transition and legacy device risks

Some devices already placed on the EU market before mandatory use may still fall under transitional timelines. This makes buyer due diligence more complex, not less complex.

Procurement teams should ask whether the device is an MDR device, IVDR device, or legacy device under transitional provisions. They should also confirm whether future supply depends on certificate validity, notified body capacity, or pending registration steps.

This is where many sourcing mistakes happen. A product can appear available today but become difficult to purchase later if the supplier has weak regulatory planning.

The practical procurement takeaway

EUDAMED does not remove the need for supplier vetting. It raises the standard for what good vetting should include.

For buyers, the practical workflow is clear: verify the actor, match the device identity, check the certificate, ask about market surveillance, and document every mismatch before approval. If any answer is unclear, pause the shortlist until the supplier provides evidence.

Manufacturers listed on Suplivia are structured around verified supplier profiles, product data, and certification visibility. Buyers can use that information as an initial sourcing layer, then apply EUDAMED checks before final supplier qualification.